Effects of the fluoroquinolone difloxacin on articular-epiphyseal cartilage in growing beagle dogs have been described by light microscopic, electron microscopic, and biochemical methods. Here we present data from an immunohistochemistry study with humeral head cartilage from 3-mo-old beagle dogs after treatment with 1 or 2 oral doses of 300 mg difloxacin/kg body weight. Dogs were euthanatized either 24 hr (single dose) or 48 hr (2 doses) after onset of dosing, and cartilage tissue was stored at -90&deg;C until it was studied by immunohistochemistry. Antibodies against matrix components (collagen II, fibronectin) as well as antibodies against cellular structures (integrins) were used. After single-dose treatment (24-hr group), cartilage lesions such as clefts were not observed, but increased staining for fibronectin was found in cartilage samples from 5 of 6 animals. Markedly increased staining for fibronectin was also demonstrated in the vicinity of clefts within cartilage of all animals of the 48-hr group. Collagen II staining was homogeneously distributed in cartilage from controls and was slightly reduced in territorial matrix in 2 of 6 dogs of the 48-hr group. Integrin staining on chondrocytes was not significantly affected by difloxacin under the given conditions with the exception of a slight reduction of the &alpha; v integrin chain in 1 of 5 dogs of the 48-hr group. Overall, the most important result is the finding that fibronectin was a sensitive immunohistochemical marker for change in cartilage samples due to difloxacin treatment in dogs.
INTRODUCTION
The propensity for quinolone antibacterial drugs to induce arthropathy in articular cartilages of growing animals (articular-epiphyseal complex) has been well documented (for review, see references 3, 13, 14) . The shortterm temporal effects of the fluoroquinolone difloxacin (at 300 mg/kg body weight) on articular cartilages in growing dogs have been described by Burkhardt et al using light microscopic (5) , electron microscopic (6) , and biochemical (4) methods. Results of these studies implicate the chondrocyte rather than the extracellular matrix as the component of cartilage initially sensitive to the arthropathic effect of difloxacin.
Light and electron microscopic changes of quinolone arthropathy have also been described in articular cartilages of rats, monkeys, and various other mammals. Immunohistochemical studies of articular cartilages from growing rats and marmosets dosed with ofloxacin revealed treatment-related changes in antigen expression within chondrocytes and extracellular matrix (12, 25) . In cartilage from marmosets that had received ofloxacin for 5 days, an increase in fibronectin staining was observed in matrix adjacent to fissures and in some areas without fissures (25) . In cartilage from rats that had been dosed with ofloxacin, a similar increase of fibronectin and a reduced expression of various integrins (e.g., the fibronectin receptor avr3¡) on chondrocytes was detected (12) . The present study was undertaken to similarly investigate immunohistochemical changes in articular cartilages from dogs dosed with difloxacin. Because the temporal progression of the difloxacin-induced lesion in the beagle dog has been well characterized by morphologic and biochemical methods, the present study sought to characterize immunohistochemical changes that may occur within either chondrocytes or extracellular matrix of cartilage within 48 hr after onset of treatment.
MATERIALS AND METHODS

Treatment with Difloxacin
Seventeen 3-mo-old beagle dogs (Marshal Farms, North Rose, NY) were housed in runs in a room maintained at 20 to 25°C and exposed to light on a cycle of 12 hr off and 12 hr on. Dogs were provided with feed and water ad libitum and were acclimated to their kennels for a minimum of 5 days prior to the onset of experimentation. Powdered difloxacin (Abbott Laboratories, Abbott Park, IL) contained in gelatin capsules was administered orally at a dose of 300 mg/kg body weight before the dogs were euthanatized at predetermined times by intravenous injection of pentobarbital.
Five control dogs were given empty gelatin capsules at 0 and 24 hr and euthanatized at 48 hr. Six dogs were dosed with difloxacin at 0 hr and euthanatized at 24 hr, whereas another 6 dogs were dosed with difloxacin at 0 and 24 hr and were euthanatized at 48 hr. Articular cartilages from do2s were also used for histolo2ic and bio-477 FIG. 5.-Articular cartilage from juvenile dogs stained with an antibody against the a&dquo; chain of integrin receptors. a) Untreated control. Uniformly strong expression of the <Xv chain on chondrocytes throughout the entire depth of cartilage (X 130). b) After treatment with 2 X 300 mg difloxacin/kg body weight (48-hr group), a cleft is present within the intermediate zone of the articular cartilage. Expression of a~ chain is slightly reduced on chondrocytes that line the cleft margin (X 130). chemical analyses and these results have been reported previously (4) . Articular cartilage from humeral heads were used for immunohistochemical evaluation in the present study. Immediately after dogs were euthanatized, full-thickness slices of articular-epiphyseal cartilage were collected into glass vials, frozen on dry ice, and stored at -90°C. Cartilage slices were subsequently packed on dry ice and transported to a second laboratory (R.S.) for immunohistochemical staining.
Immunohistochemistry
Cartilage samples were thawed and 6 or 7 pieces per dog were embedded in Tissue TEK (Miles Diagnostics, Elkhardt, IN) without fixation or decalcification and subsequently refrozen by immersion in liquid nitrogen. Cryosections (approximately 7-pLm thick) were prepared from cartilage samples of all animals of each group and mounted on poly-L-lysine-coated glass slides.
Cartilage sections from dogs of the 48-hr group were stained in 3 independent experiments with a primary anti- Collagen II is homogeneously distributed in the territorial and interterritorial matrix throughout the entire depth of articular cartilage (X 130). b) After treatment with 2 X300 mg difloxacin/kg body weight (48-hr group), collagen II has been depleted from the territorial matrix throughout the entire cartilage layer (the cartilage laceration is an artifact of tissue collection; X 130). c) After treatment with 2 X 300 mg difloxacin/kg body weight (48-hr group), a cleft is present within the intermediate zone of the articular cartilage. Staining of collagen II is normal within the extracellular matrix (X 130). body against cartilage matrix molecules (fibronectin, collagen II) or cellular structures (ot,-integrin chain). The sections from the 24-hr group were investigated with the antibody against fibronectin only. Slices were incubated at 4°C overnight, washed 3 times in phosphate-buffered saline (Ca2+-and Mg2+-free), and subsequently stained with a second FITC-labeled antibody for 30 min at room temperature. Control for nonspecific staining was achieved by assuring the absence of fluorescence in samples prepared either with PBS only or without use of the primary antibody. Results are reported as the consensus of 2 independent, nonblinded observers who performed subjective evaluation for intensity and topography of staining patterns. In all cases, staining patterns of tissue from treated animals were compared to those of concurrent controls.
Antibodies against the matrix components fibronectin and collagen II were prepared at the Institut fur Klinische Pharmakologie und Toxikologie, Freien Universitat Berlin, and specified by ELISA-techniques (1, 10) . Integrin expression on chondrocytes was analyzed by using antibodies directed against the av chain of integrins (anti-ay, [CD51], Biermann, Bad Nauheim, Germany; AB 1930). The FITC-labeled goat antirabbit IgG was from Nordic, Tiburg, Netherlands.
RESULTS
Changes in the Cartilage Matrix
In cartilage samples from untreated control dogs, only small amounts of fibronectin were distributed throughout the cartilage matrix (Fig. 1 ). In cartilage samples from dogs of the 24-hr group (1 X 300 mg difloxacin/kg body weight), gross-structural lesions such as clefts were not observed, but markedly increased staining for fibronectin was found in territorial and interterritorial matrix of cartilage samples from 5 of 6 animals, particularly within the intermediate zone (Fig. 2 ). After treatment with 2 X 300 mg difloxacin/kg body weight, increased expression of fibronectin was observed in the extracellular matrix adjacent to clefts within the intermediate zone of cartilage. This alteration was observed in cartilage samples of all animals of the 48-hr group and was the most sensitive immunohistochemical marker in cartilage samples from difloxacin-treated dogs (Fig. 3a, b ). Intensity of fluorescence varied slightly among the samples, indicating varying amounts of fibronectin in the tissue. However, if the intensity of fluorescence is to be compared on different photomicrographs, it must be remembered that brightness increases as a function of increased magnification.
The effect of difloxacin on collagen II was investigated following treatment with 2 X 300 mg difloxacin/kg body weight (48-hr group). Collagen II was homogeneously distributed in the cartilage matrix of untreated control dogs (Fig. 4a ). The effects of difloxacin treatment were not consistent in all animals investigated. In cartilage samples of 2 difloxacin-treated dogs, staining for collagen II was reduced in the territorial region of the matrix (Fig.   4b ). However, similar alterations were not observed in the vicinity of cartilage clefts in samples of 4 further difloxacin-treated dogs (Fig. 4c ).
Integrin Staining
Staining for the av chain of integrins was strongly detected in all zones of humeral head cartilage from untreated juvenile dogs (Fig. 5a ). Difloxacin treatment did not affect staining for the av chain in cartilage samples from 4 of 5 dogs of the 48-hr group. However, in sections of cartilage from I dog, staining for the a~ subunit was slightly reduced on chondrocytes in the immediate proximity of a gross-structural cartilage lesion (Fig. 5b) . Quantity of articular cartilage from the sixth dog was insufficient to allow evaluation for integrin in tissue.
DISCUSSION
Initial changes reported in articular cartilage from dogs dosed with difloxacin were ultrastructural and consisted of cytoplasmic vacuolation of chondrocytes 24 hr after administration of 1 X 300 mg difloxacin/kg body weight (6) . After treatment with 2 X 300 mg/kg body weight, a progressive loss of collagen from the matrix was evident biochemically, and necrosis of chondrocytes and disruption of extracellular matrix were evident by light microscopy (4, 5) . Forty-eight hr after onset of difloxacin treatment,-chondrocytes had mitochondrial swelling and necrosis, progressing to matrix destruction (4-6). Temporally, these observations appeared to indicate that initial changes occurred in the chondrocyte rather than extracellular matrix 24 hr after difloxacin treatment.
In the present study, increased expression of fibronectin was observed in extracellular matrix at 24 hr in articular cartilages, which lacked histologic changes such as the presence of edema or clefts in the cartilage matrix. Increased staining for fibronectin was observed, particularly in the intermediate zone of the cartilage (i.e., the site in which the quinolone lesion develops). After dosing with 2 X 300 mg difloxacin/kg body weight (48-hr group), marked increase in fibronectin staining was found within the extracellular matrix in all dogs investigated (Fig. 2 ). Comparison of these new data with the published data (4) (5) (6) precludes the present authors from identifying whether either the chondrocyte or the extracellular matrix was the primary target for difloxacin-induced cartilage damage. Additionally, it is noteworthy that characteristic quinolone-induced changes have been demonstrated in guinea pig articular cartilage that had been previously depleted of viable chondrocytes by iodoacetate (2) .
Staining for collagen II was reduced in cartilages of some dogs from the 48-hr difloxacin group. This finding was interpreted as being somewhat in agreement with the biochemical data obtained previously from cartilages of the same dogs, in which mean concentration of total collagen was approximately 7% less than that obtained from controls (4) . The biochemical assay apparently had sufficient precision to detect minor reductions in collagen that were not detectable by the more subjective immunohistochemical method. Moreover, results of the present study confirm that loss of collagen occurs as an early secondary event within articular cartilages of dogs dosed with difloxacin. The pattern of fibronectin expression observed in ar-ticular cartilage of dogs in the present study closely resembled that reported in other species. In knee-joint cartilage from marmosets (Callithrix jacchus) dosed with ofloxacin, increased expression of fibronectin was topographically and quantitatively similar to that of dogs from the present study. In marmoset controls, however, chondrocytes in knee-joint cartilage were not as strongly positive for the antibody as were those in the canine samples (25) .
The glycoprotein fibronectin can interact with both cell surface and extracellular matrix components and mediates cell adhesion, migration, differentiation, and other cellular functions (21) . In normal cartilage, fibronectin is only a minor component but is known to be elevated in degenerated cartilage of several animal species (7, 8) . The mechanism by which quantity of fibronectin is increased in degenerative cartilage is unknown. The short duration (24 hr) in which expression of the glycoprotein was increased in the present study was consistent with a mechanism involving unmasking of preexisting fibronectin within matrix rather than increased synthesis only. It is doubtful that a sufficiently large increase in chondrocyte fibronectin synthesis and subsequent marked diffusion into interterritorial matrix could have occurred within the short 24-hr period to account alone for the observed increase in staining.
Increase of fibronectin staining in articular cartilage has been identified as a very sensitive indicator and early reaction after quinolone treatment in immature rats and marmosets (12, 25) . F6rster et al (12) described increased fibronectin in knee-joint cartilage from immature rats after oral treatment with ofloxacin or from rats that had been kept on a magnesium-deficient diet for 9 days. In controls, fibronectin was not associated with cellular structures but rather was unequally distributed throughout the matrix. After exposure to ofloxacin or induction of magnesium deficiency, fibronectin was strongly enriched in the vicinity of cartilage clefts. These results supported the finding that quinolone-induced changes are indistinguishable from those of magnesium deficiency in rats, as shown by light and electron microscopy (23, 24) .
Quinolones are potent chelating agents (16, 17, 20) and there is emerging evidence that they damage juvenile joint cartilage of animals due to their chelating properties, in particular by forming stable chelate complexes with magnesium (24, 27) . In this respect, it is of interest that lameness and gait alterations closely resembling quinolone-induced arthropathy were described in magnesiumdeficient dogs almost 4 decades ago (26) . After 3 or 4 weeks on a magnesium-deficient diet, juvenile dogs stood with pronounced hyperextension of their carpo-metacarpal joints, which is a typical posture resulting from quinolone treatment (3) . Lack of histologic data from the 1958 study preclude further comparisons.
Integrins are important adhesion molecules that mediate binding of matrix molecules to chondrocytes (7, 9, 11, 18, 19, 22) . Information about immunohistochemical alterations of integrin expression on chondrocytes after quinolone treatment must be interpreted with caution because a lack of change in antigen expression would not preclude the existence of functional changes. Conversely, F6rster et al (12) observed a decrease of staining for integrins in articular cartilage of rats that had been treated with ofloxacin for 8 days. It was not clear whether the down-regulation of the receptor was the initial event in quinolone-induced arthropathy or simply a consequence of the cell damage.
The antibody used in the present study was directed against the av subunit, which has been reported to form heterodimers with several (3-chains that mediate cell adhesion to fibronectin and other molecules (9, 15) . The avr33 integrin has been demonstrated in articular cartilage of humans (28) and rats (12) but has not been previously described in canine cartilage. The present authors observed a slight reduction of the expression of the cx~-subunit on chondrocytes in the vicinity of a fissure in I dog. If this result is compared with previous data from rats, it must be remembered that there were major differences between the protocols of the 2 studies (species, drug, dose, and treatment duration). Because quinolones have been shown to produce identical changes regardless of which combination of quinolone analogue and sensitive species is used (3, 14) , duration may be the significant variable between the 2 studies. Perhaps depletion of a~subunits on chondrocytes evolves over the period between day 2 and day 8. In summary, one of the most consistent findings in immature joint cartilage from at least 3 different species (rats, dogs, and nonhuman primates) is an increase of fibronectin following quinolone treatment. Increased staining for the glycoprotein is demonstrable in specimens that lack gross and histologic changes in the middle layer of the articular-epiphyseal cartilage. In samples with fissures, fibronectin is enriched around the lesions. Thus, an increase in fibronectin expression can be considered a sensitive marker for quinolone-induced arthropathy, and immunohistochemical studies are a reasonable approach to investigate this unusual effect.
